Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

EVOK Evoke Pharma Inc

4,64

0,17 (3,80%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Evoke Pharma Charts.

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Evoke Pharma Charts.

News Evoke Pharma Inc

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
Donnerstag 19 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
Dienstag 3 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 22 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 28 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
Montag 28 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
Mittwoch 23 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 22 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Evoke Pharma Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen